Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Labianca

Showing results (41-50 of 174) with videos related to

Pageof 18
Sort By:
Clinical Drug Investigation|February 8, 2013
The appropriate treatment of chronic painPiercarlo Sarzi-Puttini, Renato Vellucci, Stefano Maria Zuccaro, et al.
Clinical Drug Investigation|February 24, 2012
The appropriate treatment of chronic painPiercarlo Sarzi-Puttini, Renato Vellucci, Stefano Maria Zuccaro, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2017
Second line with oxaliplatin- or irinotecan-based chemotherapy for gemcitabine-pretreated pancreatic cancer: A systematic reviewFausto Petrelli, Alessandro Inno, Antonio Ghidini, et al.
Critical Reviews in Oncology/Hematology|May 14, 2005
Gastric cancerVincenzo Catalano, Roberto Labianca, Giordano D Beretta, et al.
Critical Reviews in Oncology/Hematology|February 24, 2009
Gastric cancerVincenzo Catalano, Roberto Labianca, Giordano D Beretta, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 10, 2016
Borderline resectable pancreatic cancer: More than an anatomical conceptFausto Petrelli, Alessandro Inno, Sandro Barni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Are dose-finding studies still necessary when targeted therapy is associated with chemotherapy?Alain J Gelibter, Sara Lonardi, Susanna Di Segni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 7, 2005
Edmonton symptom assessment scale: Italian validation in two palliative care settingsCecilia Moro, Cinzia Brunelli, Guido Miccinesi, et al.
Thrombosis Research|April 13, 2016
Hypercoagulation screening as an innovative tool for risk assessment, early diagnosis and prognosis in cancer: the HYPERCAN studyAnna Falanga, Armando Santoro, Roberto Labianca, et al.
Journal of Cancer Policy|January 29, 2026
Investigational sites requirements according to trial complexity and intervention level under EU Regulation No. 536/2014Celeste Cagnazzo, Evaristo Maiello, Roberto Labianca, et al.
Pageof 18

Showing results (41-50 of 174) with videos related to

Sort By:
Pageof 18
Clinical Drug Investigation|February 8, 2013
The appropriate treatment of chronic painPiercarlo Sarzi-Puttini, Renato Vellucci, Stefano Maria Zuccaro, et al.
Clinical Drug Investigation|February 24, 2012
The appropriate treatment of chronic painPiercarlo Sarzi-Puttini, Renato Vellucci, Stefano Maria Zuccaro, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2017
Second line with oxaliplatin- or irinotecan-based chemotherapy for gemcitabine-pretreated pancreatic cancer: A systematic reviewFausto Petrelli, Alessandro Inno, Antonio Ghidini, et al.
Critical Reviews in Oncology/Hematology|May 14, 2005
Gastric cancerVincenzo Catalano, Roberto Labianca, Giordano D Beretta, et al.
Critical Reviews in Oncology/Hematology|February 24, 2009
Gastric cancerVincenzo Catalano, Roberto Labianca, Giordano D Beretta, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 10, 2016
Borderline resectable pancreatic cancer: More than an anatomical conceptFausto Petrelli, Alessandro Inno, Sandro Barni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Are dose-finding studies still necessary when targeted therapy is associated with chemotherapy?Alain J Gelibter, Sara Lonardi, Susanna Di Segni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 7, 2005
Edmonton symptom assessment scale: Italian validation in two palliative care settingsCecilia Moro, Cinzia Brunelli, Guido Miccinesi, et al.
Thrombosis Research|April 13, 2016
Hypercoagulation screening as an innovative tool for risk assessment, early diagnosis and prognosis in cancer: the HYPERCAN studyAnna Falanga, Armando Santoro, Roberto Labianca, et al.
Journal of Cancer Policy|January 29, 2026
Investigational sites requirements according to trial complexity and intervention level under EU Regulation No. 536/2014Celeste Cagnazzo, Evaristo Maiello, Roberto Labianca, et al.
Pageof 18